The Hippo signaling pathway regulates cellular proliferation and survival during tissue growth and cancer. In CD4+ T cells, members of the Hippo family modulate autoimmune inflammation by altering interactions between the transcription factors Foxp3 and RORγt; this reveals an unexpected non-canonical role for Hippo in adaptive immunity.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zhou, L. & Littman, D.R. Curr. Opin. Immunol. 21, 146–152 (2009).
Geng, J. et al. Nat. Immunol. 18, 800–812 (2017).
Yu, F.X., Zhao, B. & Guan, K.L. Cell 163, 811–828 (2015).
Harvey, K.F., Zhang, X. & Thomas, D.M. Nat. Rev. Cancer 13, 246–257 (2013).
Nehme, N.T. et al. Blood 119, 3458–3468 (2012).
Li, J. et al. J. Biol. Chem. 290, 30762–30770 (2015).
Du, X. et al. J. Immunol. 192, 1525–1535 (2014).
Varelas, X. et al. Nat. Cell Biol. 10, 837–848 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
McGeachy, M. A Hippo in the Fox(p3) house. Nat Immunol 18, 709–711 (2017). https://doi.org/10.1038/ni.3769
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.3769